Prostate Cancer Metastatic

Showing 1 - 25 of 90

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • La Jolla, California
    • +1 more
    Feb 2, 2023

    Prostate Cancer Metastatic Trial in New York, Knoxville (HB-302/HB-301 Alternating 2-Vector Therapy)

    Recruiting
    • Prostate Cancer Metastatic
    • HB-302/HB-301 Alternating 2-Vector Therapy
    • New York, New York
    • +1 more
    Feb 1, 2023

    Prostate Cancer Metastatic Trial in United States (ARV-766)

    Recruiting
    • Prostate Cancer Metastatic
    • ARV-766 Part A
    • ARV-766 Part B
    • Duarte, California
    • +20 more
    Jan 31, 2023

    Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed

    Recruiting
    • Prostate Cancer
    • +4 more
    • Aalst, Belgium
    • +6 more
    Jan 25, 2023

    Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

    Recruiting
    • Cervical Cancer
    • +5 more
    • Chicago, Illinois
    • +3 more
    Jan 24, 2023

    Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

    Recruiting
    • Prostate Cancer Metastatic
    • Neuroendocrine Tumors
    • Duarte, California
    • +2 more
    Jan 18, 2023

    Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Relugolix Pill
    • +2 more
    • (no location specified)
    Dec 23, 2022

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

    Active, not recruiting
    • Advanced Cancer
    • +16 more
    • Scottsdale, Arizona
    • +3 more
    Dec 22, 2022

    Prostate Cancer Metastatic Trial in Ghent (radical prostatectomy, Whole pelvis radiotherapy)

    Recruiting
    • Prostate Cancer Metastatic
    • radical prostatectomy
    • Whole pelvis radiotherapy
    • Ghent, Belgium
      University Hospital Ghent
    Dec 16, 2022

    Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

    Recruiting
    • Prostate Cancer Metastatic
    • +3 more
    • Stereotactic body radiotherapy
    • +3 more
    • Herlev, Capital Region, Denmark
      Department of Oncology, Copenhagen University Hospital Herlev an
    Dec 16, 2022

    Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer Trial in Worldwide (radiation, procedure, drug)

    Active, not recruiting
    • Prostate Cancer
    • +3 more
    • whole pelvic radiotherapy
    • +3 more
    • Melbourne, Australia
    • +28 more
    Dec 12, 2022

    Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • +2 more
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 28, 2022

    Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)

    Recruiting
    • Prostate Cancer Metastatic
    • Peking, China
      Peking Union Medical College Hospital
    Nov 25, 2022

    Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

    Recruiting
    • Prostate Cancer Metastatic
    • Ablative Radiation Therapy
    • Standard of care
    • Victoria, British Columbia, Canada
    • +14 more
    Nov 14, 2022

    Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

    Recruiting
    • Prostate Cancer Metastatic
    • Prostate Cancer
    • Houston, Texas
    • +2 more
    Oct 7, 2022

    Androgen Deprivation Therapy, Prostate Cancer, Prostate Cancer Metastatic Trial in Boston (Aerobic and resistance exercise,

    Recruiting
    • Androgen Deprivation Therapy
    • +2 more
    • Aerobic and resistance exercise
    • Usual Care
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Oct 4, 2022

    Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • New York, New York
      Weill Cornell Medicine - New York Presbyterian Hospital
    Oct 3, 2022

    Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • (no location specified)
    Sep 29, 2022

    Prostate Cancer Metastatic Trial in France (Darolutamide 300 mg, Placebo, Androgen deprivation therapy)

    Recruiting
    • Prostate Cancer Metastatic
    • Darolutamide 300 mg
    • +2 more
    • Avignon, France
    • +44 more
    Sep 28, 2022

    Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission

    Available
    • Prostate Cancer
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Sep 27, 2022

    Prostate-Specific Membrane Antigen PET Scans in People Prostate

    Recruiting
    • Prostate Cancer
    • +4 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 29, 2022

    Prostate Cancer Metastatic Trial in Worldwide (ARV-110 in Combination with Abiraterone)

    Recruiting
    • Prostate Cancer Metastatic
    • ARV-110 in Combination with Abiraterone
    • Santa Monica, California
    • +16 more
    Jul 21, 2022